Cellular Therapies for Cancer Treatment

Advancements in Drug Delivery Strategies

Häftad, Engelska, 2026

AvArun Kumar Singh,Neeraj Mishra,Anoop Kumar,Pranav Kumar Prabhakar

2 319 kr

Kommande

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies explores the innovative use of cellular therapy to combat cancer, placing an emphasis on state-of-the-art delivery approaches. By covering a variety of cellular therapies for cancer, such as stem cells, immune cells, and others, this book provides a comprehensive introduction to the field. It describes ways to deliver drugs that target cancer cells more efficiently, decrease off-target effects, and enhance therapy outcomes. Sections provide a brief overview of cancer cell biology, describe the need for advance drug delivery systems, and address challenges and future directions.

The book also goes into the ideas behind cellular therapies and how they may overcome drug resistance and make existing cancer treatments more effective. By elaborating on the value of diversity and inclusion in cancer research and treatment, the book also emphasizes the importance of all patients having equal access to innovative therapies. All things considered, this book is a great tool for researchers, doctors, and students in the cancer treatment sector.

Gives a comprehensive overview of cellular therapies for cancer treatment, covering basic principles and advanced applications
Provides access to the latest research advancements, emerging trends, and innovative methodologies in clinical biochemistry
Offers real-world case studies and practical insights, illustrating how clinical biochemistry principles are applied in healthcare and research

Produktinformation

Utgivningsdatum2026-11-01
Mått191 x 235 x undefined mm
FormatHäftad
SpråkEngelska
Antal sidor440
FörlagElsevier Science
ISBN9780443341410

Tillhör följande kategorier

Tillverkningsindustri inom Ekonomi och Ledarskap
Farmakologi inom Medicin

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at Vivekanand Global University, where he is involved in teaching and interdisciplinary research. His academic interests span nano-formulation, artificial intelligence, machine learning, big data analytics, Internet of Things (IoT), blockchain, cancer biology, and neuroscience.He has contributed to scholarly literature through a book published with IOP Publishing, five book chapters with River Publishers, and 28 review articles in peer-reviewed journals, including publications in Biochimica et Biophysica Acta (BBA) – Reviews on Cancer.He has also authored and edited books with publishers such as Elsevier, CRC Press, and Wiley. His work focuses on the integration of pharmaceutical sciences with emerging technologies, with an emphasis on interdisciplinary research and healthcare-related applications.Dr. Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Gwalior. He has extensive teaching and research experience in pharmaceutics, with particular expertise in novel drug delivery systems, localized and targeted drug delivery, and nanocarrier-based therapeutics for cancer and neurodegenerative disorders. His research interests focus on advanced pharmaceutical formulations and controlled delivery approaches aimed at improving therapeutic outcomes.Dr. Mishra has supervised postgraduate and doctoral research scholars and has contributed widely to academic literature through research publications, books, and book chapters with leading international publishers. He is also associated with innovation in pharmaceutical sciences through patented research contributions. Over the course of his career, he has received several academic and scientific recognitions for his contributions to teaching, research, and pharmaceutical education. He has additionally been recognized internationally for his research impact and scholarly contributions in the field of pharmaceutical sciences.Dr. Anoop Kumar is an Assistant Professor in the Department of Pharmacology at Delhi Pharmaceutical Sciences & Research University (DPSRU), India. With a distinguished career, he has previously served as an Assistant Professor and Head at the National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, and as Head and Associate Professor at ISF College of Pharmacy, Moga, Punjab. Dr. Kumar has also held research positions at Sun Pharmaceutical Industries Limited and Translational Health Science Institute (THSTI). He earned his Ph.D. from Birla Institute of Technology, Mesra, Ranchi, as a DST INSPIRE Fellow. He is an Associate Editor for Health Sciences Review and Acta Neurologica Scandinavica. His research focuses on drug repurposing, clinical trial meta-analysis, pharmacoeconomics, and pharmacovigilance. Dr. Pranav Kumar Prabhakar is currently working as a Professor and Head at Department of Biotechnology, School of Engineering and Technology, Nagaland University, Meriema, Kohima, Nagaland, India. He is among the World’s Top 2% Scientists (list published by Stanford University, USA, 2021, 2022, 2023, 2024, and 2025). He completed his PhD in Biotechnology from IIT Madras. His research focuses on elucidating molecular mechanisms and strategies for oral insulin delivery and mimicking signaling pathways in metabolic disorders (diabetes) using natural products. Dr. Pranav is a member of the Royal Society of Chemistry and the Asia-Pacific Chemical, Biological & Environmental Engineering Society. He serves as an editorial board member and reviewer for many reputed national and international journals. His honors include a travel grant from IIT Madras and the Council for Scientific and Industrial Research (CSIR) to attend ATTD 2009 in Greece, approved by the Department of Science and Technology (DST). He has published over 160+ research articles, authored/edited 24 books, and 48 book chapters, and delivered 9 oral and poster presentations at scientific meetings.

1. A Brief Overview of Cancer Cell Biology2. Emerging need for advanced drug delivery systems in cancer3. Drug Delivery Systems for Cellular Therapies4. Cell-based drug delivery for cancer treatment5. Erythrocyte cell-based drug delivery for cancer treatment6. Adipocyte cell-based drug delivery for cancer treatment7. Platelet cell-based drug delivery for cancer treatment8. Mesenchymal Stem cell-based drug delivery for cancer treatment9. Natural killer cell-based drug delivery in cancer treatment10. Macrophages and Monocytes cell-based drug delivery in cancer treatment11. Neutrophils-based drug delivery in cancer treatment12. Dendritic cell-based drug delivery for cancer treatment13. Myeloid-derived suppressor cell-based drug delivery for cancer treatment14. Challenges and future directions associate with Cellular Therapies for Cancer Treatment